Inactive Instrument

GlaxoSmithKline Consumer Nigeria Plc

GLAXOSMITH

NGGLAXOSMTH8

Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2020

March 31, 2021 at 07:04 am EDT

GlaxoSmithKline Consumer Nigeria Plc announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was NGN 21,295.249 million compared to NGN 20,760.320 million a year ago. Net income was NGN 622.230 million compared to NGN 917.104 million a year ago.

Latest news about GlaxoSmithKline Consumer Nigeria Plc

GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-30	CI
GSK Nigeria calls an end to its business, to return cash	23-08-03	RE
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-03	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-01-27	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-27	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-10-28	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-29	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-31	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-25	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-29	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-31	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-23	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the First Quarter Ended March 31, 2020	20-06-11	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-29	CI
Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-07-26	CI
GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months of 2017; Provides Earnings Guidance for the Year 2017	17-10-24	CI
Suntory Beverage & Food Limited completed the acquisition of bottling and distribution of drinks from GlaxoSmithKline Consumer Nigeria Plc.	16-09-29	CI
GlaxoSmithKline Consumer Goods Nigeria Plc Declares Special Dividend	16-07-26	CI
Suntory Beverage & Food Limited made an offer to acquire bottling and distribution of drinks from GlaxoSmithKline Consumer Nigeria Plc for ¥7 billion.	16-01-24	CI
GlaxoSmithKline Consumer Nigeria Plc Announces Management Changes	14-01-15	CI
GlaxoSmithKline To Continue With Its Plan To Acquire Nigerian Unit	13-11-26	CI
GlaxoSmithKline Consumer Nigeria PLC : GSK drops scheme to raise stake in Nigerian unit	13-07-22	RE

Chart GlaxoSmithKline Consumer Nigeria Plc

Duration

Period

Chart GlaxoSmithKline Consumer Nigeria Plc

More charts

Company Profile

GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+33.25%	699B
NOVO NORDISK A/S	+24.78%	571B
JOHNSON & JOHNSON	-3.55%	364B
MERCK & CO., INC.	+18.16%	326B
ABBVIE INC.	+4.36%	286B
ASTRAZENECA PLC	+14.83%	236B
NOVARTIS AG	+5.51%	198B
ROCHE HOLDING AG	-9.82%	194B
AMGEN INC.	-3.69%	149B

Other Pharmaceuticals